Histamine H1 Receptor-Mediated CREB Phosphorylation via Gq Protein Signaling and Arrestin Modulation
Ryosuke Ogami, Shotaro Michinaga, Yosuke Iiboshi, Yasuhiro Ogawa, Shigeru Hishinuma

TL;DR
This study reveals how histamine H1 receptors activate CREB through Gq proteins and calcium, and how arrestins influence this process.
Contribution
The paper identifies Gq protein and arrestin roles in H1 receptor-mediated CREB phosphorylation.
Findings
Histamine-induced CREB phosphorylation occurs via Gq protein and calcium/PKC pathways.
Arrestins modulate CREB phosphorylation by regulating its basal levels.
S487A mutant receptors fail to induce CREB phosphorylation unlike S487Trunc.
Abstract
Background/Objectives: Histamine H1 receptors mediate multiple physiological and pathophysiological processes, including inflammation and allergy, by regulating downstream gene expression via transcription factors. cAMP response element-binding protein (CREB) is a major transcription factor whose phosphorylation is regulated by multiple signaling pathways. Although CREB is closely involved in multiple physiological and pathophysiological processes, the detailed intracellular signaling pathway of H1 receptor-mediated CREB phosphorylation remains to be elucidated. We investigated the roles of Gq proteins and arrestins in H1 receptor-mediated CREB phosphorylation. Methods: We constructed Chinese hamster ovary (CHO) expressing human wild-type (WT) H1 receptors and two types of C-terminal mutants. One mutant was constructed by truncating the serine 487 residue only at the C-terminus…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMast cells and histamine · Receptor Mechanisms and Signaling · Polyamine Metabolism and Applications
1. Introduction
G protein-coupled receptors (GPCRs) possess seven transmembrane domains and orchestrate various cellular responses in both health and disease states [1,2,3]. Upon agonist binding, GPCRs mediate various intracellular signaling pathways through both G proteins and arrestins [4,5,6,7,8]. In receptors such as β-adrenergic, angiotensin II AT_1_, and opioid receptors, these proteins mediate distinct signaling pathways that contribute to both therapeutic and adverse effects of drugs [9,10,11,12,13,14]. Therefore, separate analyses of G protein- and arrestin-dependent signaling pathways are essential to elucidate their differential roles in pathological mechanisms and inform the development of novel therapeutic drugs.
The histamine H_1_ receptor is a major GPCR expressed throughout the human body, including the central nervous system (CNS) and peripheral tissues. It regulates multiple physiological and pathophysiological processes, including allergy, inflammation, arousal, and memory [15,16,17,18,19,20,21]. Upon binding to its agonist, the H_1_ receptor activates G_q_ proteins, leading to an increase in intracellular Ca^2+^ concentration and activation of protein kinase C (PKC) through phospholipase C-mediated hydrolysis of phosphatidylinositol-4,5-bisphosphate. This H_1_ receptor-mediated activation of PKC stimulates mitogen-activated protein kinases, including extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK), contributing to allergic and inflammatory reactions. These reactions are mediated by the production of inflammatory cytokines and growth factors, along with the upregulation of H_1_ receptor gene expression [22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38]. Simultaneously, H_1_ receptors are phosphorylated by G protein-coupled receptor kinases (GRKs) and internalized via the arrestin/clathrin/dynamin pathway [39,40], enabling arrestin-mediated signal transduction. We have previously constructed two mutants of human H_1_ receptors, S487Trunc and S487A, in which the Ser487 residue at the end of the intracellular C-terminus was truncated or substituted with alanine, respectively [40]. The S487Trunc receptor appeared to be G_q_ protein-biased, mediating histamine-induced inositol phosphate production but not internalization of H_1_ receptors. In contrast, the S487A receptor was arrestin-biased, mediating histamine-induced internalization but not inositol phosphate production [40]. Using Chinese hamster ovary (CHO) cells expressing these H_1_ receptor mutants, we demonstrated that S487Trunc receptors mediate ERK and JNK phosphorylation via G_q_ protein/Ca^2+^/PKC-dependent signaling pathways. Conversely, we found that S487A receptors mediate ERK phosphorylation, but not JNK phosphorylation, via GRK/arrestin/clathrin/Raf/MEK-dependent signaling pathways [41,42]. The G_q_ protein/Ca^2+^/PKC-mediated pathway induces prompt and transient ERK phosphorylation, whereas the GRK/arrestin/clathrin-mediated pathway triggers delayed and sustained ERK phosphorylation via activation of H_1_ receptors [41].
cAMP response element-binding protein (CREB) is a general transcription factor involved in homeostatic cellular processes, including proliferation, survival, and differentiation [43]. CREB undergoes phosphorylation via multiple signaling pathways and then binds to specific DNA sequences known as cAMP response elements to regulate the transcription of target genes. It plays critical roles in inflammatory responses by controlling the production of proinflammatory cytokines and key immune functions in T cells, B cells, and macrophages [43,44]. CREB is essential for neuronal function in the CNS. For example, it acts as a positive regulator of memory formation and long-term potentiation [45]. Notably, histamine promotes CREB phosphorylation via H_1_ receptor-mediated PKC-dependent ERK activation [31]. However, it remains unclear whether H_1_ receptor-mediated CREB phosphorylation is regulated by differential activation of ERK via G_q_ protein/Ca^2+^/PKC-dependent and GRK/arrestin/clathrin/Raf/MEK-dependent pathways. Therefore, in the present study, we aimed to explore the roles of G_q_ proteins and arrestins in regulating H_1_ receptor-mediated CREB phosphorylation in CHO cells expressing wild-type (WT) human H_1_, G_q_ protein-biased S487Trunc, or arrestin-biased S487A receptors.
2. Results
2.1. Concentration- and Time-Dependency of Histamine-Induced CREB Phosphorylation
We initially examined the concentration-dependent effects of histamine on CREB phosphorylation in CHO cells expressing WT receptors by treating them with different concentrations of histamine (0.1–1000 µM) for 30 min. The ratio of phosphorylated CREB to total CREB was significantly increased in response to exposure to histamine concentrations above 1 µM and peaked at 100 μM, whereas the ratio of total CREB to β-actin remained unchanged (Figure 1A). In CHO cells expressing G_q_ protein-biased S487Trunc receptors, treatment with histamine significantly increased the ratio of phosphorylated CREB to total CREB (Figure 1B), whereas no significant effect was observed in CHO cells expressing arrestin-biased S487A receptors (Figure 1C). In CHO-K1 cells without genetic manipulation of H_1_ receptor expression, the ratio of phosphorylated CREB to total CREB was unaffected by treatment with 100 μM histamine for 30 min (Figure 2).
We then assessed the time-dependent effects of histamine (100 µM) on CREB phosphorylation. In CHO cells expressing WT receptors and G_q_ protein-biased S487Trunc, histamine-induced CREB phosphorylation occurred within 10 min and persisted for 60–180 min (Figure 3A,B). In contrast, histamine-induced CREB phosphorylation did not occur in CHO cells expressing arrestin-biased S487A receptors not only for the 30 min histamine treatment shown in Figure 1C but also for other histamine treatment times (Figure 3C).
To further evaluate whether arrestin-dependent endocytic pathways could be involved in histamine-induced CREB phosphorylation, we treated CHO cells expressing WT receptors with or without histamine (100 µM, 10 min) in the presence or absence (vehicle) of inhibitors of GRK2/3 (cmpd101; 30 μM), clathrin (0.32 M sucrose), and dynamin (dynasore; 100 μM) (Figure 4). None of these inhibitors significantly inhibited CREB phosphorylation, indicating that histamine-induced CREB phosphorylation occurs via G_q_ protein-dependent rather than arrestin-dependent signaling. Therefore, we conducted subsequent experiments to explore the signaling pathways underlying the induction of CREB phosphorylation by treatment with 100 µM histamine for 10 min in CHO cells expressing WT and G_q_ protein-biased S487Trunc receptors.
2.2. Involvement of Gq Protein/Ca2+/PKC-Dependent Pathways in H1 Receptor-Mediated CREB Phosphorylation
To confirm whether histamine-induced CREB phosphorylation occurred via H_1_ receptors, we assessed the effects of an antihistamine, ketotifen (1000 μM), on histamine-induced CREB phosphorylation. Histamine-induced CREB phosphorylation was completely inhibited by ketotifen in CHO cells expressing WT (Figure 5A) and S487Trunc receptors (Figure 5B). We then investigated the involvement of G_q_ proteins in histamine-induced CREB phosphorylation. Treatment with the G_q_ protein inhibitor, YM-254890 (20 µM), significantly inhibited histamine-induced CREB phosphorylation in CHO cells expressing WT (Figure 6A) and S487Trunc receptors (Figure 6B). These results suggest that H_1_ receptor-mediated CREB phosphorylation occurred via G_q_ protein-dependent signaling pathways.
As G_q_ proteins mediate Ca^2+^/PKC-dependent signaling pathways, we investigated the effects of the intracellular Ca^2+^ chelator, BAPTA-AM (50 µM), and a PKC inhibitor, GF109203X (10 µM), on histamine-induced CREB phosphorylation. Both BAPTA-AM and GF109203X significantly inhibited histamine-induced CREB phosphorylation in CHO cells expressing WT (Figure 6C) or S487Trunc receptors (Figure 6D). These results suggest that H_1_ receptor-mediated CREB phosphorylation occurred via G_q_ protein/Ca^2+^/PKC-dependent signaling pathways.
2.3. Involvement of ERK and JNK in H1 Receptor-Mediated CREB Phosphorylation
In our previous study, we found that H_1_ receptor-mediated activation of the G_q_ protein/Ca^2+^/PKC pathway induces the phosphorylation of ERK and JNK [41,42]. Therefore, in this study, we assessed the potential involvement of ERK and JNK in histamine-induced CREB phosphorylation. Our results indicated that histamine-induced CREB phosphorylation was significantly inhibited by the ERK inhibitor SCH772984 (20 µM) or the JNK inhibitor SP600125 (20 µM) in CHO cells expressing WT (Figure 7A,C) and S487Trunc receptors (Figure 7B,D) although SCH772984 or SP600125 treatment partially suppressed the phosphorylation of basal CREB. These findings suggest that H_1_ receptor-mediated CREB phosphorylation occurs via G_q_ protein/Ca^2+^/PKC-dependent activation of ERK and JNK.
2.4. Possible Involvement of Arrestins in Regulating the Basal Levels of CREB Phosphorylation and H1 Receptor-Mediated CREB Phosphorylation
To investigate the possible involvement of arrestins in CREB phosphorylation, we overexpressed β-arrestin1 or β-arrestin2 in CHO cells expressing WT receptors. Overexpression of either β-arrestin1 or β-arrestin2 significantly increased CREB phosphorylation in CHO cells both in the presence and absence of histamine for 10 min (Figure 8A), suggesting increased basal CREB phosphorylation levels. To further assess the impact of arrestin overexpression on histamine-induced CREB phosphorylation, we treated CHO cells overexpressing β-arrestin1 or β-arrestin2 with histamine for 30–180 min (Figure 8B,C). Histamine-induced CREB phosphorylation was enhanced in the presence of overexpressed β-arrestin1 (Figure 8B) or β-arrestin2 (Figure 8C). This result suggests modulation of basal CREB phosphorylation levels. Conversely, siRNA-mediated knockdown of β-arrestin1 or β*-arrestin2* in CHO cells expressing WT receptors tended to lower the basal level of CREB phosphorylation in the absence of histamine (Figure 9A). The knockdown of either protein did not markedly affect CREB phosphorylation following 10 min of treatment with histamine (Figure 9A). However, during prolonged stimulation (30–180 min), the knockdown of β-arrestin1 (Figure 9B) or β-arrestin2 (Figure 9C) decreased histamine-induced CREB phosphorylation. Collectively, these results suggest that arrestins regulate the basal level of CREB phosphorylation and thereby modulate H_1_ receptor-mediated, G_q_ protein/Ca^2+^/PKC-dependent phosphorylation of CREB.
3. Discussion
To the best of our knowledge, the present study is the first to reveal the differential roles of G_q_ proteins and arrestins in H_1_ receptor-mediated CREB phosphorylation. We have recently demonstrated that H_1_ receptor-mediated ERK phosphorylation is regulated through two distinct pathways: the G_q_ protein/Ca^2+^/PKC and GRK/arrestin/clathrin/Raf/MEK pathways [41]. We have also revealed that H_1_ receptor-mediated JNK phosphorylation is regulated by G_q_ protein/Ca^2+^/PKC-dependent but GRK/arrestin/clathrin-independent pathways [42]. Building upon these findings, in the present study, we explored the signaling pathways underlying H_1_ receptor-mediated CREB phosphorylation in CHO cells expressing WT, G_q_ protein-biased mutant S487Trunc, and arrestin-biased mutant S487A.
3.1. Histamine H1 Receptor-Mediated CREB Phosphorylation Is Predominantly Induced via Gq Protein/Ca2+/PKC-Mediated Activation of ERK and JNK
Our present results revealed that histamine promoted CREB phosphorylation in CHO cells expressing WT and G_q_ protein-biased S487Trunc. Moreover, histamine-induced CREB phosphorylation was inhibited by antihistamine, G_q_ protein inhibitor, intracellular Ca^2+^ chelator, and inhibitors of PKC, ERK, and JNK. These results suggest that H_1_ receptor-mediated CREB phosphorylation is regulated via G_q_ protein/Ca^2+^/PKC-dependent activation of ERK and JNK. Notably, these results are consistent with several reports indicating that CREB phosphorylation is mediated by ERK and JNK [46,47], while histamine-induced CREB phosphorylation is mediated via PKC-dependent activation in human aortic endothelial cells [31]. Furthermore, not only histamine-induced CREB phosphorylation but also basal CREB phosphorylation was partially inhibited by the inhibitors of dynamin, G_q_ protein, PKC, ERK, and JNK, suggesting that these pathways may also contribute to basal CREB phosphorylation.
We focused only on G_q_ protein but not G_11_ protein in this study. Although G_q_ protein and G_11_ protein largely initiate similar signaling cascades, they may have distinct roles in specific physiological and pathophysiological situations. For this consideration, observation of CREB phosphorylation by knockdown G_q_ and G_11_ with their siRNA should be performed to determine whether G_11_ participated in the H_1_ mediated CREB phosphorylation through Ca^2+^/PKC signaling in the future.
In the present study, histamine did not increase CREB phosphorylation in CHO cells expressing arrestin-biased S487A. In addition, histamine-induced CREB phosphorylation in CHO cells expressing WT was not affected by inhibitors of GRKs, clathrin, and dynamin. These results suggest that arrestins are not affected by histamine-induced CREB phosphorylation in CHO cells expressing WT receptors, although they have been reported to mediate H_1_ receptor-dependent ERK phosphorylation [41]. These results suggest that differences in the spatial patterns of G protein- and arrestin-mediated ERK activation may lead to differential activation of CREB [48].
3.2. Arrestins Regulate the Basal CREB Phosphorylation Level and Modulate H1 Receptor-Mediated CREB Phosphorylation
In the present study, overexpression of β-arrestin1 or β-arrestin2 increased basal CREB phosphorylation levels, whereas their knockdown decreased them, thereby modulating H_1_ receptor-mediated CREB phosphorylation. These results are consistent with a previous report demonstrating that elevated β-arrestin2 expression leads to increased CREB phosphorylation in cystic fibrosis cells [49]. Collectively, these results suggest that basal CREB phosphorylation is likely regulated by arrestin expression within the cell.
As a mechanism of CREB regulation via arrestins, Manson et al. have suggested that CREB regulation is mediated directly through β-arrestin2 expression via the ERK pathway [50]. Furthermore, β-arrestin can activate ERK signaling independently of G proteins [51]. We previously found that G_q_ protein-mediated ERK activation was prompt and transient, whereas arrestin-mediated ERK activation was delayed and persistent [41]. These findings suggest that arrestin-mediated ERK activation may be involved in sustaining and enhancing CREB phosphorylation. However, ERK-independent mechanisms of CREB activation may also exist. As our previous studies indicated that basal phosphorylation level of ERK is not affected by arrestin2 knockdown [41], arrestin-mediated increases in basal CREB phosphorylation may also result from a direct interaction between arrestins and CREB [50,52].
3.3. Physiological and Pathophysiological Roles of H1 Receptor-Mediated CREB Regulation
H_1_ receptor-mediated signaling pathways induce inflammation by increasing the production of proinflammatory cytokines [27,28,29,35]. CREB regulates the production of proinflammatory cytokines and various immune functions [43,44]. As previously described, H_1_ receptors play crucial roles in maintaining wakefulness and memory formation in the CNS [53]. Notably, CREB is a positive regulator of memory formation and long-term potentiation [45] and is required in excitatory neurons of the forebrain to sustain wakefulness [54]. Therefore, CREB phosphorylation via G_q_ proteins, and potentially arrestins, may contribute to the physiological and pathophysiological regulation of peripheral and CNS function by H_1_ receptors.
However, this study has some limitations. First, we did not reveal the detailed mechanism by which arrestins are involved in CREB phosphorylation. Second, as we only used CHO cells overexpressing H_1_ receptors in this study, confirmation using cells that naturally express H_1_ receptors is also necessary. Third, we have not performed the in vivo experiments to analyze the roles of G_q_ protein and arrestins on CREB phosphorylation. Although the mutation at serine 487 residue in the C-terminus of the H_1_ receptor has not been reported in humans and the associated disease phenotype has not been elucidated, analyzing the phenotype through the in vivo knock-in experiments of H_1_ receptor mutants used in this study may elucidate how G_q_ protein and arrestins are involved in CREB phosphorylation under physiological and pathophysiological conditions. Therefore, further studies are required to strengthen the conclusions of this study.
4. Materials and Methods
4.1. Preparation of CHO Cells Expressing WT or Mutant Human Histamine H1 Receptors
All genetic modification studies were approved by the Institutional Safety Committee for Recombinant DNA Experiments of Meiji Pharmaceutical University (Approval No. 1209). CHO-K1 cells (RCB0285, RRID: CVCL_0214) were obtained from RIKEN Bioresource Center (Ibaraki, Japan). CHO cells stably expressing human WT histamine H_1_ receptors and two types of C-terminal mutants. One mutant was constructed by truncating the serine 487 residue only at the C-terminus of the H_1_ receptor (S487Trunc), and the other was constructed by substituting the serine 487 residue at the C-terminus of the H_1_ receptor with alanine (S487A), which was previously established in our laboratory [40,41,42]. These CHO cells were incubated in Dulbecco’s modified Eagle’s medium (catalog number: 08460-95, Gibco, Grand Island, NY, USA) containing G418 sulfate (Enzo Life Sciences, Inc., Farmingdale, NY, USA) and 10% (v/v) fetal bovine serum (Biowest, Nuaillé, France) cultured in 150 cm^2^ culture flasks (BM Bio, Tokyo, Japan) at 37 °C in a 5% CO_2_ incubator. Upon reaching confluence, CHO cells were dissociated with trypsin/EDTA (Sigma-Aldrich, St. Louis, MO, USA) and reseeded in six-well culture plates (Corning Inc., Corning, NY, USA) for subsequent experiments.
4.2. Drug Treatments
Forty-eight hours before drug treatments, CHO cells were incubated in a serum-free medium in 6-well plates at 37 °C in a 5% CO_2_ incubator. First, the concentration- and time-dependent effects of histamine on CREB phosphorylation were investigated in CHO cells treated with varying concentrations (0.1–1000 µM) of histamine (Sigma-Aldrich) for 30 min or with a fixed concentration of histamine (100 µM) for varying durations (10–360 min). Subsequently, the effects of various inhibitors on histamine-induced CREB phosphorylation were assessed. CHO cells were treated with 100 µM histamine for 10 min in the presence of the following inhibitors: H_1_ receptor antagonist (ketotifen; Sigma-Aldrich) [41], G_q_ protein inhibitor (YM-254890; FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) [55], intracellular Ca^2+^ chelator (BAPTA-AM; Abcam, Cambridge, UK) [56], PKC inhibitor (GF109203X; Sigma-Aldrich) [57], ERK inhibitor (SCH772984; Selleckchem, Houston, TX, USA) [58], JNK inhibitor (SP600125; FUJIFILM Wako Pure Chemical Corporation) [59], GRK2/3 inhibitor (cmpd101; Hello Bio, Bristol, UK) [60], and dynamin inhibitor (dynasore; Sigma-Aldrich) [61]. Histamine treatment was performed under hypertonic conditions (0.32 M sucrose; FUJIFILM Wako Pure Chemical Corporation) to inhibit the formation of clathrin-coated pits [62].
4.3. Immunoblotting Analysis
CHO cells were collected and homogenized in 150 µL of radioimmunoprecipitation assay buffer (Nacalai Tesque, Kyoto, Japan) containing protease cocktails (Nacalai Tesque) and phosphatase inhibitor cocktails (Nacalai Tesque) to extract proteins. The collected cell lysates were centrifuged at 20,000 × g for 10 min (Model 3700; KUBOTA, Tokyo, Japan). Supernatants were collected as protein samples for immunoblotting analyses, and the protein content in the supernatant was determined using the Pierce™ bicinchoninic acid protein assay kit (Thermo Fisher Scientific, Waltham, MA, USA). Proteins were subjected to electrophoresis in a 7.5% polyacrylamide gel and transferred onto polyvinylidene difluoride membranes (MilliporeSigma, Burlington, MA, USA). The membranes were placed in the SNAP.i.d.^®^ 2.0 (MilliporeSigma) and were incubated with Blocking One (Nacalai Tesque) for 30 min before the antibody reaction. The antibodies were diluted in Blocking One and were prepared fresh each time. The membranes were then incubated with primary antibodies against CREB (1:4000; #4820, Cell Signaling Technology, Danvers, MA, USA), phosphorylated CREB (1:4000; #9198, Cell Signaling Technology), β-arrestin1 (1:4000; ab32096, Abcam), and β-arrestin2 (1:4000; ab54790, Abcam) for 1 h and then reacted with peroxidase-conjugated secondary antibody (1:4000; #12-348 or #12-349, MilliporeSigma) for 30 min. After detecting CREB or arrestins, antibodies were stripped by incubating the membranes with WB Stripping Solution (Nacalai Tesque) for 5 min, and the membranes were washed with Tris-buffered saline with Tween 20 (Nacalai Tesque). The membranes were incubated with primary antibodies against β-actin (1:4000; ab317794, Abcam), and then incubated with a peroxidase-conjugated secondary antibody (1:4000; AP180P, MilliporeSigma). Proteins were detected using a chemiluminescence kit (Chemi-Lumi One^®^ L; Nacalai Tesque). The intensity of the protein bands was determined using ImageJ software (version 1.53c; National Institutes of Health, Bethesda, MD, USA). The molecular weights of proteins were assessed using Precision Plus Protein™ Kaleidoscope™ Prestained Protein Standards (Bio-Rad Laboratories, Hercules, CA, USA). In the corresponding figures, representative immunoblot images of phosphorylated CREB (phospho-CREB; 43 kDa), CREB (total CREB; 43 kDa), β-arrestin1 (50 kDa), β-arrestin2 (50 kDa), and β-actin (40 kDa) are presented together with bar graphs. The arrowheads indicate phosphorylated CREB in the immunoblot images. The lower bands of phosphorylated CREB represent phosphorylated ATF-1, a CREB-related protein, according to an antibody datasheet as of 27 January 2026 (https://www.cellsignal.jp/products/primary-antibodies/phospho-creb-ser133-87g3-rabbit-mab/9198). Histamine-induced changes in the ratios of phosphorylated CREB to total CREB (phospho-CREB/total CREB) and total CREB to β-actin (total CREB/β-actin) are presented as percentages of the control in the bar graphs.
4.4. Overexpression of β-arrestin1/2
Overexpression of yellow fluorescent protein (YFP)-conjugated β-arrestin1 or 2 (gifted from Robert Lefkowitz; Addgene plasmids 36916 and 36917, Addgene, Watertown, MA, USA) was performed via electroporation (Poring pulse: voltage 175) [63]. β-arrestin protein overexpression was confirmed via immunoblotting.
4.5. Knockdown of β-arrestin1/2 Through Small Interfering RNA (siRNA)
Knockdown of β-arrestin1 or β-arrestin2 was achieved via transient transfection of siRNAs. β-arrestin1 siRNA, β-arrestin2 siRNA, and control siRNA (catalog number: sc-37007) were obtained from Santa Cruz Biotechnology (Dallas, TX, USA). These siRNAs were transfected into CHO cells (70–80% confluence) in six-well plates using siRNA transfection reagent in siRNA transfection medium (Santa Cruz Biotechnology), according to the manufacturer’s protocol and our previous study [41]. CHO cells were collected 48 h after siRNA treatment for the immunoblotting assay.
4.6. Statistical Analysis
Statistical analysis and Normality tests were conducted using Ekuseru-Toukei (BellCurve for Excel, Social Survey Research Information Co., Ltd., Tokyo, Japan). The four independent experiments were performed in this study. Assessment of the normality of the data and testing for outlier was performed using the Shapiro–Wilk test and Smirnov-Grubbs’test, respectively. The Statistical analysis was applied to the normalized data sets. Data are presented as mean ± standard error (SE). Statistical analysis was performed using one-way analysis of variance followed by post hoc tests (Dunnett’s test or Tukey’s test). Statistical significance was set at p < 0.05.
5. Conclusions
We demonstrated that histamine H_1_ receptor-mediated CREB phosphorylation is induced through G_q_ protein/Ca^2+^/PKC-dependent activation of ERK and JNK. In contrast, arrestins regulate the basal level of CREB phosphorylation, thereby enhancing or maintaining H_1_ receptor-mediated CREB phosphorylation. However, further investigations, including in vivo studies using experimental animals and in vitro studies using cells that naturally express H_1_ receptors, are required to provide novel insights into the role of CREB in H_1_ receptor-mediated physiological and pathophysiological responses.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Pierce K.L. Premont R.T. Lefkowitz R.J. Seven-transmembrane receptors Nat. Rev. Mol. Cell Biol.2002363965010.1038/nrm 90812209124 · doi ↗ · pubmed ↗
- 2Fredriksson R. Lagerström M.C. Lundin L.G. Schiöth H.B. The G-protein-coupled receptors in the human genome form five main families: Phylogenetic analysis, paralogon groups, and fingerprints Mol. Pharmacol.2003631256127210.1124/mol.63.6.125612761335 · doi ↗ · pubmed ↗
- 3Lefkowitz R.J. Seven transmembrane receptors: Something old, something new Acta Physiol.200719091910.1111/j.1365-201X.2007.01693.x 17428228 · doi ↗ · pubmed ↗
- 4Drake M.T. Shenoy S.K. Lefkowitz R.J. Trafficking of G protein-coupled receptors Circ. Res.20069957058210.1161/01.RES.0000242563.47507.ce 16973913 · doi ↗ · pubmed ↗
- 5De Wire S.M. Ahn S. Lefkowitz R.J. Shenoy S.K. Beta-arrestins and cell signaling Annu. Rev. Physiol.20076948351010.1146/annurev.physiol.69.022405.15474917305471 · doi ↗ · pubmed ↗
- 6Shenoy S.K. Lefkowitz R.J. β-arrestin-mediated receptor trafficking and signal transduction Trends Pharmacol. Sci.20113252153310.1016/j.tips.2011.05.00221680031 PMC 3159699 · doi ↗ · pubmed ↗
- 7Jean-Charles P.Y. Kaur S. Shenoy S.K. G protein-coupled receptor signaling through beta-arrestin-dependent mechanisms J. Cardiovasc. Pharmacol.20177014215810.1097/FJC.000000000000048228328745 PMC 5591062 · doi ↗ · pubmed ↗
- 8Gurevich V.V. Gurevich E.V. GPCR signaling regulation: The role of GR Ks and arrestins Front. Pharmacol.20191012510.3389/fphar.2019.0012530837883 PMC 6389790 · doi ↗ · pubmed ↗
